Using breath analysis for quick diagnosis of respiratory diseases
Official title: Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
Run by Oregon Health and Science University · NCT06775106 · Data updated 2026-11-12
This study is testing a new way to quickly diagnose respiratory diseases by analyzing the breath of patients on ventilators to see if it can help detect problems earlier.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 120 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Oregon Health and Science University Academic / other |
| Locations | 1 site (Portland, Oregon) |
| Status | Recruiting |
| Started | November 30, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | January 14, 2025 |
| Trial ID | NCT06775106 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are non-COVID-19 adult patients over 18 years old who are on ventilatory support in the ICU.
✕Probably not a fit
Patients experiencing severe respiratory distress or hemodynamic instability may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to validate a novel technique using mass spectrometry to analyze exhaled breath from non-COVID ICU patients on ventilation. The study will employ Orbitrap and MALDI mass spectrometry to capture and analyze proteins in breath samples, correlating these findings with existing clinical data to enhance early detection of pulmonary diseases. By focusing on ventilator-dependent patients, the study seeks to establish a rapid diagnostic tool that could be utilized in non-ICU settings for respiratory pathogen detection.
Why it matters
Potential benefit: If successful, this technique could lead to faster and more accurate diagnoses of respiratory diseases, improving patient outcomes.
How similar studies have gone: While the approach is innovative, similar studies using breath analysis for disease detection have shown promise, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Non-COVID-19 adult consented patients (\>18yo) on ventilatory support in the ICU at OHSU Exclusion Criteria: * Patients with "severe respiratory distress" as defined by arterial pO2 of \<60 mmHg on maximal FiO2 \& optimal ventilator settings * Patient with severe hemodynamic instability as defined by (a) receiving IV infusion of 2 or more pressors or inotropic medications (Levophed, vasopressin, phenylephrine, or epinephrine) \& (b) MAP of \<60 mmHg or SB \<80 mmHg
Where it's running
-
Oregon Health and Science University
Portland, Oregon, United States Recruiting
Study contacts
- Study coordinator: Laura H Nguyen, B.S.
- Email: nguyelau@ohsu.edu
- Phone: 503-418-4733
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Cycling with immersive VR for ICU patients recovering from critical illness
In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.
-
Factors Influencing Outcomes in ECMO and Impella Patients
This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.